Back

Prognostic value of left ventricular hypertrophy in patients with myocardial fibrosis by ECV mapping on cardiac MRI

25 August 2023 (15:15 - 15:55)
Organised by: Logo
Congress Presentation Part of: CMR tissue characterisation: why it matters Extracellular Volume ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Loba Alam

Mount Sinai Morningside, Icahn School of Medicine at Mount Sinai, New York City (United States of America)

7 More presentations in this session

Presentation thumbnail
Risk stratification in patients with structurally normal hearts: does fibrosis type matter?
Assistant Professor K. Gil (Columbus, US)
Abstract Slides Video
Presentation thumbnail
Cardiac troponin T and I are differentially associated with myocardial fibrosis assessed by cardiac magnetic resonance imaging
Doctor M. Paus (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
Left ventricular fibrosis influences the time to recovery in patients with arrhythmia-induced cardiomyopathy
Doctor D. Lavall (Leipzig, DE)
Abstract Slides Video
Presentation thumbnail
Association of late-gadolinium enhancement on cardiac magnetic resonance with cardiovascular outcomes and mortality in patients with aortic stenosis
Doctor S. Moussa (Stony Brook, US)
Abstract Slides Video
Presentation thumbnail
Association of epicardial adipose tissue on magnetic resonance imaging with cardiovascular outcomes: Quality over quantity?
Doctor F. Duca (Vienna, AT)
Abstract Slides Video

Access the full session

Session thumbnail
CMR tissue characterisation: why it matters

The Event

Event poster

ESC Congress 2023

25 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Session
Prognostication in left ventricular hypertrophy: role of cardiac magnetic resonance imaging
thumbnail
Congress Presentation
Prognostic value of left ventricular phenotypes in patients with hypertensive heart disease using cardiac magnetic resonance
thumbnail
Congress Presentation
Clinical characteristics and outcomes of left ventricular hypertrophy in severe primary mitral regurgitation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources